UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis

International journal of molecular sciences, 2021-06, Vol.22 (13), p.6921

2021

Link zum Volltext

Verfügbarkeit prüfen

Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells

International journal of molecular sciences, 2020-10, Vol.21 (20), p.7588

2020

Link zum Volltext

Verfügbarkeit prüfen

Rifaximin enhances the L‑carnitine‑mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut‑liver‑muscle axis

International journal of molecular medicine, 2022-08, Vol.50 (2), p.1, Article 101

2022

Link zum Volltext

Verfügbarkeit prüfen

Association between Equol Production Status and Nonalcoholic Steatohepatitis

International journal of molecular sciences, 2021-11, Vol.22 (21), p.11904

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the efficacy and safety between palliative biliary stent placement and duct clearance among elderly patients with choledocholithiasis: a propensity score-matched analysis

BMC gastroenterology, 2021-10, Vol.21 (1), p.1-369, Article 369

2021

Link zum Volltext

Verfügbarkeit prüfen

Association between Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study

Journal of clinical medicine, 2020-05, Vol.9 (6), p.1635

2020

Link zum Volltext

Verfügbarkeit prüfen

VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma

BMC gastroenterology, 2019-10, Vol.19 (1), p.167-167, Article 167

2019

Link zum Volltext

Verfügbarkeit prüfen

The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure

Biology (Basel, Switzerland), 2023-01, Vol.12 (2), p.164

2023

Link zum Volltext

Verfügbarkeit prüfen

Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity

Cells (Basel, Switzerland), 2023-02, Vol.12 (5), p.687

2023

Link zum Volltext

Verfügbarkeit prüfen

The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects

Cells (Basel, Switzerland), 2021-03, Vol.10 (3), p.575

2021

Link zum Volltext

Verfügbarkeit prüfen

Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis

Microorganisms (Basel), 2020-06, Vol.8 (6), p.925

2020

Link zum Volltext

Verfügbarkeit prüfen

Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients

Clinical and Molecular Hepatology, 2019, 25(4), , pp.381-389

2019

Link zum Volltext

Verfügbarkeit prüfen

A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation

Biomedicines, 2023-04, Vol.11 (5), p.1295

2023

Link zum Volltext

Verfügbarkeit prüfen

ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability

Journal of clinical medicine, 2022-03, Vol.11 (7), p.1835

2022

Link zum Volltext

Verfügbarkeit prüfen

Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis

Journal of clinical medicine, 2021-06, Vol.10 (11), p.2465

2021

Link zum Volltext

Verfügbarkeit prüfen

Increased Endotoxin Activity Is Associated with the Risk of Developing Acute-on-Chronic Liver Failure

Journal of clinical medicine, 2020-05, Vol.9 (5), p.1467

2020

Link zum Volltext

Verfügbarkeit prüfen

Hydralazine Sensitizes to the Antifibrotic Effect of 5-Aza-2′-deoxycytidine in Hepatic Stellate Cells

Biology (Basel, Switzerland), 2020-06, Vol.9 (6), p.117

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment of long-segment Barrett's adenocarcinoma by complete circular endoscopic submucosal dissection: a case report

BMC gastroenterology, 2018-01, Vol.18 (1), p.16-16, Article 16

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification of the Response-Related Biomarker of Bimonthly Hepatic Arterial Infusion Chemotherapy

Journal of clinical medicine, 2021-02, Vol.10 (4), p.629

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection

Clinical and Molecular Hepatology, 2019, 25(1), , pp.65-73

2019

Link zum Volltext

Verfügbarkeit prüfen

Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat

BMC research notes, 2009-05, Vol.2 (1), p.70-70

2009

Link zum Volltext

Verfügbarkeit prüfen

Accuracy of Fibrosis-4 Index in Identification of Patients with Cirrhosis Who Could Potentially Avoid Variceal Screening Endoscopy

Journal of clinical medicine, 2020-10, Vol.9 (11), p.3510

2020

Link zum Volltext

Verfügbarkeit prüfen

Su1049 Changes in Fatty Liver Over the Past 20 Years: Association With Lifestyle-Related Diseases

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-1049-S-1050

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis

Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells

Rifaximin enhances the L‑carnitine‑mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut‑liver‑muscle axis

Association between Equol Production Status and Nonalcoholic Steatohepatitis

Comparison of the efficacy and safety between palliative biliary stent placement and duct clearance among elderly patients with choledocholithiasis: a propensity score-matched analysis

Association between Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study

VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma

The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure

Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity

The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects

Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis

Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients

A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation

ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability

Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis

The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria

Increased Endotoxin Activity Is Associated with the Risk of Developing Acute-on-Chronic Liver Failure

Hydralazine Sensitizes to the Antifibrotic Effect of 5-Aza-2′-deoxycytidine in Hepatic Stellate Cells

Treatment of long-segment Barrett's adenocarcinoma by complete circular endoscopic submucosal dissection: a case report

Identification of the Response-Related Biomarker of Bimonthly Hepatic Arterial Infusion Chemotherapy

Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection

Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat

Accuracy of Fibrosis-4 Index in Identification of Patients with Cirrhosis Who Could Potentially Avoid Variceal Screening Endoscopy

Clinical Significance of Gamma-Glutamyltranspeptidase Combined with Carbohydrate-Deficient Transferrin for the Assessment of Excessive Alcohol Consumption in Patients with Alcoholic Cirrhosis

Su1049 Changes in Fatty Liver Over the Past 20 Years: Association With Lifestyle-Related Diseases

Aktive Filter

Suchergebnisse filtern